Nanomaterials for promoting axon regeneration after spinal cord injury: Mechanisms and prospects
The effects of clinical therapies for spinal cord injury (SCI) are greatly limited due to poor axon regeneration. This review systematically discusses the ability of nanomaterials (NMs) to treat SCI and the mechanism underlying their therapeutic effects. The properties of NMs that are conducive to axon regeneration after SCI are outlined.
Jia Liu+9 more
wiley +1 more source
Nef is a key player in neuroinflammation and myelin impairment associated with neuroHIV. [PDF]
Bukrinsky MI.
europepmc +1 more source
Encephalitogenicity of myelin basic protein exon-2 peptide in mice
Robert B. Fritz, Ming‐Lang Zhao
openalex +1 more source
ABSTRACT Introduction/Objectives: Agoutis is a medium‐sized wild rodent with potential for use as an experimental model. This study aimed to evaluate physiological parameters of arrhythmogenesis in this species, by HR‐ECG and VCG techniques, under physical and pharmacological containment (ketamine‐xylazine and butorphanol). Materials and methods: Eight
Charlys Rhands Coelho de Moura+9 more
wiley +1 more source
Low-Intensity Pulsed Ultrasound Promotes Oligodendrocyte Maturation and Remyelination by Down-regulating the Interleukin-17A/Notch1 Signaling Pathway in Mice with Ischemic Stroke. [PDF]
Wang J+7 more
europepmc +1 more source
<b>MYELIN P<sub>0</sub> PROTEIN EXPRESSED IN C6 CELLS PROMOTES NEURITE OUTGROWTH </b>
Takahito Yazaki+4 more
openalex +2 more sources
Trends in resource utilization for new‐onset psychosis hospitalizations at children's hospitals
Abstract Background Children with new‐onset psychosis often require hospitalization for medical evaluation. Objectives The goal of this study was to assess variations in the management of children with new‐onset psychosis and characterize trends in resource utilization.
Ankita Gupta+8 more
wiley +1 more source
Tuina promotes nerve myelin regeneration in SNI rats through Piezo1/YAP/TAZ pathway. [PDF]
Xu Y+8 more
europepmc +1 more source
MR‐Guidance of Gene Therapy for Brain Diseases: Moving From Palliative Treatment to Cures
ABSTRACT Regulatory bodies in the U.S. and Europe recently approved a gene therapy for aromatic L‐amino acid decarboxylase (AADC) deficiency, a rare neurologic disorder where a genetic mutation prevents dopamine production in the brain. Affected children fail to develop normal motor and cognitive functions.
Dalton H. Bermudez+2 more
wiley +1 more source